These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21674721)

  • 1. Feasibility of anti-VEGF agent bevacizumab in patients with Crohn's disease.
    Coriat R; Mir O; Leblanc S; Ropert S; Brezault C; Chaussade S; Goldwasser F
    Inflamm Bowel Dis; 2011 Jul; 17(7):1632. PubMed ID: 21674721
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete remission of psoriasis following bevacizumab therapy for colon cancer.
    Akman A; Yilmaz E; Mutlu H; Ozdogan M
    Clin Exp Dermatol; 2009 Jul; 34(5):e202-4. PubMed ID: 19077094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor inhibitors in colon cancer.
    Díaz-Rubio E
    Adv Exp Med Biol; 2006; 587():251-75. PubMed ID: 17163170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caution in adding bevacizumab in the adjuvant treatment of breast cancer.
    Ziogas D; Roukos D
    Ann Surg Oncol; 2010 Feb; 17(2):653-4; author reply 655-6. PubMed ID: 19888632
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
    Willett CG; Boucher Y; di Tomaso E; Duda DG; Munn LL; Tong RT; Chung DC; Sahani DV; Kalva SP; Kozin SV; Mino M; Cohen KS; Scadden DT; Hartford AC; Fischman AJ; Clark JW; Ryan DP; Zhu AX; Blaszkowsky LS; Chen HX; Shellito PC; Lauwers GY; Jain RK
    Nat Med; 2004 Feb; 10(2):145-7. PubMed ID: 14745444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab.
    El Maalouf G; Mitry E; Lacout A; Lièvre A; Rougier P
    J Neurol; 2008 Feb; 255(2):295-6. PubMed ID: 18283405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular target therapy for colonic neoplasms].
    Oki E; Ota M; Honbo T; Egashira A; Tokunaga E; Sadanaga N; Morita M; Kakeji Y; Maehara Y
    Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):289-94. PubMed ID: 17370595
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease.
    Rutella S; Fiorino G; Vetrano S; Correale C; Spinelli A; Pagano N; Arena V; Maggiano N; Repici A; Malesci A; Danese S
    Am J Gastroenterol; 2011 Apr; 106(4):762-70. PubMed ID: 21364546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.
    Xu L; Duda DG; di Tomaso E; Ancukiewicz M; Chung DC; Lauwers GY; Samuel R; Shellito P; Czito BG; Lin PC; Poleski M; Bentley R; Clark JW; Willett CG; Jain RK
    Cancer Res; 2009 Oct; 69(20):7905-10. PubMed ID: 19826039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed news for Avastin.
    Mack GS
    Nat Biotechnol; 2009 Jun; 27(6):494. PubMed ID: 19513035
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bevacizumab (Avastin)].
    Yamazaki K; Yoshino T; Boku N
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1183-91. PubMed ID: 17687199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-VEGF therapy in proliferative diabetic retinopathy.
    Abdallah W; Fawzi AA
    Int Ophthalmol Clin; 2009; 49(2):95-107. PubMed ID: 19349790
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.
    Ferrara N; Hillan KJ; Gerber HP; Novotny W
    Nat Rev Drug Discov; 2004 May; 3(5):391-400. PubMed ID: 15136787
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-VEGF therapeutic approaches for diabetic macular edema.
    Khurana RN; Do DV; Nguyen QD
    Int Ophthalmol Clin; 2009; 49(2):109-19. PubMed ID: 19349791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bevacizumab and radiotherapy].
    Blanchard P; Besse B; Deutsch E
    Rev Mal Respir; 2008 Dec; 25(10):1319-21. PubMed ID: 19107021
    [No Abstract]   [Full Text] [Related]  

  • 16. Bevacizumab in adult malignant brainstem gliomas.
    Raza S; Donach M
    J Neurooncol; 2009 Nov; 95(2):299-300. PubMed ID: 19506812
    [No Abstract]   [Full Text] [Related]  

  • 17. Bevacizumab in the treatment of breast cancer.
    Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP
    Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiogenesis inhibitors in cancer therapy. Bevacizumab against colon carcinoma].
    Fieth C; Kebig A; Mohr K
    Pharm Unserer Zeit; 2007; 36(6):442-5. PubMed ID: 17957688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal injection of bevacizumab to treat neovascular glaucoma.
    Kubota T; Aoki R; Harada Y; Tou N; Tawara A
    Jpn J Ophthalmol; 2008; 52(5):410-412. PubMed ID: 18991046
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-VEGF therapy with bevacizumab in breast cancer].
    Tóth J; Gonda A; Szántó J
    Lege Artis Med; 2008 Oct; 18(10):669-73. PubMed ID: 19227609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.